{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T01:17:59Z","timestamp":1747358279958},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T00:00:00Z","timestamp":1233014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s12519-009-0013-6","type":"journal-article","created":{"date-parts":[[2009,1,26]],"date-time":"2009-01-26T04:57:41Z","timestamp":1232945861000},"page":"65-67","source":"Crossref","is-referenced-by-count":8,"title":["Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis?"],"prefix":"10.1007","volume":"5","author":[{"given":"Markus","family":"Treichel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Schwendener Scholl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Joeris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Nelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,27]]},"reference":[{"key":"13_CR1","unstructured":"Product information. Effexor\u00ae (venlafaxine hydrochloride) Tablets. Wyeth Pharmaceuticals Inc., 2008. www.wyeth.com\/content\/showlabeling.asp?id=99 (accessed July, 2008)."},{"key":"13_CR2","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1176\/appi.ajp.158.10.1728","volume":"158","author":"A. Einarson","year":"2001","unstructured":"Einarson A, Fatoye B, Sarkar M, Lavigne SV, Brochu J, Chambers C, et al. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry 2001;158:1728\u20131730.","journal-title":"Am J Psychiatry"},{"key":"13_CR3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archpedi.156.11.1129","volume":"156","author":"A.M. Costei","year":"2002","unstructured":"Costei AM, Kozer E, Ho T, Ito S, Koren G. Perinatal outcomes following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002;156:1129\u20131132.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"13_CR4","first-page":"1370","volume":"147","author":"R.A. Moor De","year":"2003","unstructured":"De Moor RA, Mourad L, ter Haar J, Egberts AC. Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy. Ned Tijdschr Geneeskd 2003;147:1370\u20131372.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"13_CR5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/08039480500363595","volume":"59","author":"O. Melien","year":"2005","unstructured":"Melien O, Skaali T, Myhr K, Brors O. Venlafaxine and asthma. Nord J Psychiatry 2005;59:538\u2013540.","journal-title":"Nord J Psychiatry"},{"key":"13_CR6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1592\/phco.25.4.626.61029","volume":"25","author":"R.C. Turner","year":"2005","unstructured":"Turner RC, Nelson JE, Roberts BT, Gillam DM. Venlafaxine associated interstitial penumonitis. Pharmacotherapy 2005;25:626\u2013629.","journal-title":"Pharmacotherapy"},{"key":"13_CR7","doi-asserted-by":"crossref","first-page":"F134","DOI":"10.1136\/fn.84.2.F134","volume":"84","author":"J.A. Stiskal","year":"2001","unstructured":"Stiskal JA, Kulin N, Koren G, Ho T, Ito S. Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed 2001;84:F134\u2013135.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"13_CR8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0002-9149(99)00284-2","volume":"84","author":"G.V. Nair","year":"1999","unstructured":"Nair GV, Gurbel PA, O\u2019Connor CM, Gattis WA, Murugesan SR, Serebruany VL. Depression, coronary events, platelet inhibition and serotonin reuptake inhibitors. Am J Cardiol 1999;84:321\u2013323.","journal-title":"Am J Cardiol"},{"key":"13_CR9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/978-1-4899-1813-0_56","volume":"407","author":"K. Muguruma","year":"1997","unstructured":"Muguruma K, Gray PW, Tjoelker LW, Johnston JM. The central role of PAF in necrotizing enterocolitis development. Adv Exp Med Biol 1997;407:379\u2013382.","journal-title":"Adv Exp Med Biol"},{"key":"13_CR10","first-page":"951","volume":"12","author":"L.A. Heier","year":"1991","unstructured":"Heier LA, Carpanzano CR, Mast J, Brill PW, Winchester P, Deck MD. Maternal cocaine abuse: the spectrum of radiologic abnormalities in the neonatal CNS. AJNR Am J Neuroradiol 1991;12:951\u2013956.","journal-title":"AJNR Am J Neuroradiol"},{"key":"13_CR11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/000992289503400805","volume":"34","author":"S.L. Lopez","year":"1995","unstructured":"Lopez SL, Taeusch HW, Findlay RD, Walther FJ. Time of onset of necrotizing enterocolitis in newborn infants with known prenatal cocaine exposure. Clin Pediatr (Phila) 1995;34:424\u2013428.","journal-title":"Clin Pediatr (Phila)"},{"key":"13_CR12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0022-3468(91)90988-6","volume":"26","author":"C. Czyrko","year":"1991","unstructured":"Czyrko C, Del Pin CA, O\u2019Neill JA Jr, Peckham GJ, Ross AJ 3rd. Maternal cocaine abuse and necrotizing enterocolitis: outcome and survival. J Pediatr Surg 1991;26:414\u2013418.","journal-title":"J Pediatr Surg"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-009-0013-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-009-0013-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-009-0013-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:58:42Z","timestamp":1559462322000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-009-0013-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,27]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1007\/s12519-009-0013-6","relation":{},"ISSN":["1708-8569"],"issn-type":[{"value":"1708-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1,27]]}}}